U.S. Approves ACTA While EU Abstains

  OUR LATEST ON TWITTER

Global Innovation Policy Center (GIPC) @globalIPcenter 12h

The price controls included in the Inflation Reduction Act will have a detrimental impact on biopharmaceutical innovation. Our new report has the data: https://t.co/p4hK1obVbN

Reply Retweet Favorite


Subscribe for updates from GIPC